Duke Suit Vs. Elan Targets Competing Patent Filings

Law360, New York (July 6, 2004, 12:00 AM EDT) -- Duke University has sued drug maker Elan Corp. over competing patents for a promising obesity drug.

Duke’s lawsuit, filed last month in U.S. District Court in Durham, North Carolina, accuses Elan of fraud, copyright infringement and unfair competition.

Duke is joined in the suit by Orexigen Therapeutics, a Princeton, a licensee for certain university technology.

Also named as a defendant is Eisai Ltd., the Japanese drug company that bought the rights to the drug and the associated patent application.

Duke has asked the court to declare...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.